Mesaj Rehberi | Net Pals

RobertMitchell updated the profile picture
2026-10-23 19:23:37 - Translate -

0 Yorumlar 0 hisse senetleri 303 Views 0 önizleme

Please log in to like, share and comment!
RobertMitchell bir ses eklendi Health
2026-10-23 19:35:08 - Translate -

Natera (NTRA) draws a Buy and a $475 target as Roth/MKM bets on cancer residual disease tests
Roth/MKM started coverage of Natera, Inc. (NTRA) at Buy with a $475 target, pointing to wider use of its minimal residual disease blood tests, firmer pricing and a 2027 early detection study readout. Roth/MKM started coverage of Natera, Inc. (NTRA) on Friday, October 23, 2026, with a Buy rating and a $475 price target, Investing.com reported. The firm built its case on the company's cancer...

0 Yorumlar 0 hisse senetleri 900 Views 0 önizleme

Please log in to like, share and comment!
JamesWilson updated the profile picture
2026-10-23 19:38:51 - Translate -

0 Yorumlar 0 hisse senetleri 286 Views 0 önizleme

Please log in to like, share and comment!
laser247rich bir ses eklendi Oyunlar
2026-10-23 19:43:38 - Translate -

Laser247 ID: Understanding Online Platform Access and Account Safety
Online platforms have become a common part of everyday digital entertainment. Before using any website, however, it is useful to understand how account access works, what information may be required, and how to protect personal details. If you have come across the term Laser247 ID, you may be wondering what it means and how it relates to accessing the Laser247 website. This guide explains the...

0 Yorumlar 0 hisse senetleri 354 Views 0 önizleme

Please log in to like, share and comment!
JamesWilson bir ses eklendi Other
2026-10-23 19:43:53 - Translate -

Ionis (IONS) partner Roche shows sefaxersen cut IgA nephropathy proteinuria 43.1% in Phase 3
Roche gave the first effect size from its IMAgINATION kidney trial at ASN Kidney Week, a clearer read for Ionis Pharmaceuticals Inc. (IONS) on a partnered drug that carries milestones and royalties. Sefaxersen cut proteinuria by 43.1% against placebo at 37 weeks in a Phase 3 trial in IgA nephropathy, according to data Ionis Pharmaceuticals Inc. (IONS) released on October 23. Roche Holding AG,...

0 Yorumlar 0 hisse senetleri 867 Views 0 önizleme

Please log in to like, share and comment!
seamlesssteelsolutions updated the profile picture
2026-10-23 19:45:28 - Translate -

0 Yorumlar 0 hisse senetleri 69 Views 0 önizleme

Please log in to like, share and comment!
MarkDavis updated the profile picture
2026-10-23 19:51:37 - Translate -

0 Yorumlar 0 hisse senetleri 256 Views 0 önizleme

Please log in to like, share and comment!
MarkDavis bir ses eklendi Other
2026-10-23 19:55:26 - Translate -

Kilroy Realty (KRC) leases 815,000 square feet as FFO per share falls to 88 cents
Kilroy Realty Corporation (KRC) lifted its leased rate in all five West Coast regions, but many signed tenants have yet to move in, and third quarter FFO per share fell from $1.08 a year earlier. Kilroy Realty Corporation (KRC) signed about 815,000 square feet of office leases in the third quarter, the Los Angeles landlord said in its results release on Thursday. Its leased rate rose, while...

0 Yorumlar 0 hisse senetleri 767 Views 0 önizleme

Please log in to like, share and comment!
nk99fmi bir ses eklendi Health
2026-10-23 19:56:34 - Translate -

Hair Restoration Market Outlook Highlights Advances in Follicular Unit Extraction Technology
According to the hair restoration market report published by Future Market Insights (FMI), the global hair restoration market is projected to increase from USD 8,099.40 million in 2024 to USD 18,825.30 million by 2034, registering a compound annual growth rate (CAGR) of 8.80% during the forecast period. Rising hair loss prevalence, growing acceptance of aesthetic procedures, and advances in...

0 Yorumlar 0 hisse senetleri 226 Views 0 önizleme

Please log in to like, share and comment!
EricJohnson updated the profile picture
2026-10-23 19:59:19 - Translate -

0 Yorumlar 0 hisse senetleri 267 Views 0 önizleme

Please log in to like, share and comment!